Accelerating Clinical Advances in Cellular and Gene Therapies
The Translational Science and Therapeutics (TST) Division at Fred Hutch Cancer Center is composed primarily of laboratory-based research groups that work in areas related to hematopoiesis, immunology, hematopoietic cell transplantation, immunotherapy and gene therapy. The overall goal is to advance our understanding in these research areas and to develop next generation therapies for patients with hematologic malignancies and disorders, solid tumors and infectious diseases.
Advancing Research
Our faculty includes 51 researchers focused on developing treatment options, improving patient outcomes and identifying ways to prevent complications from treatments.
Developing Therapies
Our investigators are addressing less toxic techniques for eliminating diseased cancer cells and improving the chance of matching blood products for transplantation.